Skip to main content
SpringerLink
Log in

Speicheldrüsenkarzinome

Teil I: Epidemiologie, Ätiologie, Malignitätskriterien, Prognoseparameter und Klassifikation

Salivary gland carcinomas

Part 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification

  • Weiterbildung · Zertifizierte Fortbildung
  • Published:
HNO Aims and scope Submit manuscript

Zusammenfassung

Karzinome der Kopfspeicheldrüsen umfassen eine Gruppe seltener maligner Tumoren, deren Diagnostik und Therapie anspruchsvoll sind. Gründe dafür sind die histologische Vielfalt, die den unterschiedlichen Typen entsprechend verschiedenen Krankheitsverläufe und die enge Beziehung zum N. facialis. Die vorliegende Arbeit gibt einen Überblick über Diagnostik und mögliche Therapieverfahren wie Primärtumorresektion, Neck-Dissection sowie Radiatio und analysiert die gegenwärtig diskutierten Risikofaktoren, Malignitätskriterien und Prognoseparameter vor dem Hintergrund der einschlägigen Literatur. Sie beschreibt zudem übersichtsartig klinisch-epidemiologische Daten von Patienten mit Speicheldrüsenkarzinomen, die von 1978 bis 2003 in einem Tumorregister dokumentiert wurden. Die Fortbildung ist in 2 Teile untergliedert: Der erste hat Epidemiologie, Ätiologie, Malignitätskriterien, Prognoseparameter und Klassifikation zum Inhalt, der zweite befasst sich mit der Diagnostik und Therapie von Speicheldrüsenkarzinomen.

Abstract

Salivary gland carcinomas comprise a rare group of malignant tumors which are difficult to diagnose and treat due to their histopathologic diversity, variable clinical course and anatomic location, particularly with respect to the facial nerve. The present paper summarizes important features of these tumors, including recent advances in their management, i.e., diagnosis, surgery of the primary tumor, neck dissection, radiation therapy, and updates risk factors, criteria of malignancy, and prognostic variables, taking into account the relevant literature. Additionally, the present paper highlights briefly the survival rates of patients suffering from salivary gland carcinomas. The present overview is divided into two parts: the first is focused on epidemiology, etiology, criteria of malignancy, prognostic factors, and tumor classification, while part II discusses the diagnosis and therapy of salivary gland carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY (1990) Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 116: 290–293

    PubMed  Google Scholar 

  2. Batsakis JG (1994) Staging of salivary gland neoplasms: role of histopathologic and molecular factors. Am J Surg 168: 386–390

    PubMed  Google Scholar 

  3. Becker W, Naumann HH, Pfaltz CR (1989) Hals-Nasen-Ohrenheilkunde. Kurzgefaßtes Lehrbuch mit Atlasteil. Georg Thieme, Stuttgart New York

  4. Berg JW, Hutter RV, Foote FW Jr (1968) The unique association between salivary gland cancer and breast cancer. JAMA 204: 771–774

    Article  PubMed  Google Scholar 

  5. Billroth T (1859) Beobachtungen über Geschwülste der Speicheldrüsen. Virchow Arch Pathol Physiol 17: 357–375

    Google Scholar 

  6. Buxton RW, Maxwell JH, French AJ (1953) Surgical treatment of epithelial tumors of the parotid gland. Surg Gynecol Obstet 97: 401–416

    PubMed  Google Scholar 

  7. Chilla R (1995) Diagnose und Therapie von Speicheldrüsentumoren, Teil I. HNO 43: 627–633

    PubMed  Google Scholar 

  8. Chilla R (1995) Diagnose und Therapie von Speicheldrüsentumoren, Teil II. HNO 43: 681–694

    PubMed  Google Scholar 

  9. Chomette G, Auriol M, Tranbaloc P, Vaillant JM (1982) Adenoid cystic carcinoma of minor salivary glands. Analysis of 86 cases. Clinico-pathological, histoenzymological and ultrastructural studies. Virchow Arch A Pathol Anat Histol 395: 289–301

    Article  Google Scholar 

  10. Conley J, Hamaker RC (1975) Prognosis of malignant tumors of the parotid gland with facial paralysis. Arch Otolaryngol 101: 39–41

    PubMed  Google Scholar 

  11. Ellis GL, Auclair PL (1991) Acinic cell adenocarcinoma. In: Ellis GL AP, Gnepp DR (ed) Surgical pathology of the salivary glands. W. B. Saunders Company, Philadelphia, pp 299–317

  12. Ellis GL, Auclair PL (1996) Adenocarcinoma, not otherwise specified. In: Ellis GL AP (ed) Atlas of tumor pathology: Tumors of the salivary glands. Armed Formces Institute of Pathology, Washington/DC, pp 175–182

  13. El-Naggar AK, Callender D, Coombes MM, Hurr K, Luna MA, Batsakis JG (2000) Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model? Genes Chromosomes Cancer 27: 162–168

    Article  PubMed  Google Scholar 

  14. Eneroth CM (1972) Facial nerve paralysis. A criterion of malignancy in parotid tumors. Arch Otolaryngol 95: 300–304

    PubMed  Google Scholar 

  15. Eneroth CM, Blanck C, Jakobsson PA (1968) Carcinoma in pleomorphic adenoma of the parotid gland. Acta Otolaryngol 66: 477–492

    PubMed  Google Scholar 

  16. Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H (1993) Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg 119: 517–520

    PubMed  Google Scholar 

  17. Frankenthaler RA, Luna MA, Lee SS et al. (1991) Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg 117: 1251–1256

    PubMed  Google Scholar 

  18. Gallo O, Franchi A, Bianchi S, Boddi V, Giannelli E, Alajmo E (1995) p53 oncoprotein expression in parotid gland carcinoma is associated with clinical outcome. Cancer 75: 2037–2044

    PubMed  Google Scholar 

  19. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Lang S, Zietz C, Lohrs U (2002) Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol Res Pract 198: 777–783

    PubMed  Google Scholar 

  20. Issing WJ, Dreps A, Heppt WJ, Wustrow TP, Riederer A, Zagury JF (1993) erbB-2/Her-2 gene amplification and overexpression in parotid gland tumors. Eur Arch Otorhinolaryngol 250: 150–153

    PubMed  Google Scholar 

  21. Johns ME (1980) Parotid cancer: a rational basis for treatment. Head Neck Surg 3: 132–141

    PubMed  Google Scholar 

  22. Kane WJ, McCaffrey TV, Olsen KD, Lewis JE (1991) Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg 117: 307–315

    PubMed  Google Scholar 

  23. Pedersen D, Overgaard J, Sogaard H, Elbrond O, Overgaard M (1992) Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis. Laryngoscope 102: 1064–1069

    PubMed  Google Scholar 

  24. Prior P, Waterhouse JA (1977) Second primary cancers in patients with tumours of the salivary glands. Br J Cancer 36: 362–368

    PubMed  Google Scholar 

  25. Rice DH, Batsakis JG, McClatchey KD (1976) Postirradiation malignant salivary gland tumor. Arch Otolaryngol 102: 699–701

    PubMed  Google Scholar 

  26. Rice DH, Becker TS (1994) Clinical correlations in the head and neck. In: The salivary glands: radiology, pathology. Georg Thieme, New York, pp 37–54

  27. Seifert G, Sobin LH (1991) Histological classification of salivary gland tumors. In: Organization WH (ed) International histological classification of tumours. Springer, Berlin Heidelberg New York Tokio

  28. Seifert G, Steinbach E, Holtmann S (1992) Kopfspeicheldrüsen: Tumoren. In: Oto-Rhino-Laryngologie in Klinik und Praxis. Georg Thieme, Stuttgart

  29. Spiro RH (1995) Changing trends in the management of salivary tumors. Semin Surg Oncol 11: 240–245

    PubMed  Google Scholar 

  30. Spiro RH, Huvos AG, Strong EW (1975) Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg 130: 452–459

    Article  PubMed  Google Scholar 

  31. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR (1984) Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer 54: 1854–1859

    PubMed  Google Scholar 

  32. Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, Takeyama I (1992) Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 102: 923–927

    PubMed  Google Scholar 

  33. Swoboda H, Franz P (1994) [Salivary gland tumors. Clinical aspects and therapy]. Radiologe 34: 232–238

    PubMed  Google Scholar 

  34. UICC (2002) TNM classification of malignant tumours. International Union Against Cancer. John Wiley & Sons,

  35. Vander Poorten VL, Balm AJ, Hilgers FJ et al. (1999) The development of a prognostic score for patients with parotid carcinoma. Cancer 85: 2057–2067

    PubMed  Google Scholar 

  36. Vander Poorten VL, Hart AA, van der Laan BF et al. (2003) Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985–1994 Dutch Head and Neck Oncology Cooperative Group database. Cancer 97: 1453–1463

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein — Campus Lübeck

    S. Lang, N. Rotter, B. Wollenberg & K. Sommer

  2. Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde der Ludwig-Maximilians-Universität München

    A. Lorenzen & G. Rasp

  3. Pathologisches Institut der Ludwig-Maximilians-Universität München

    S. Ihrler

  4. Tumorregister München

    R. Eckel & D. Hölzel

  5. Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde, Universitätsklinikum Schleswig-Holstein — Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck

    S. Lang

Authors
  1. S. Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Lorenzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Ihrler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Eckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Hölzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Rasp
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. Wollenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. Sommer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Lang.

Additional information

Die vollständige Literatur finden Sie in der elektronischen Version unter http://www.hno.springer.de

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lang, S., Rotter, N., Lorenzen, A. et al. Speicheldrüsenkarzinome. HNO 53, 817–828 (2005). https://doi.org/10.1007/s00106-005-1293-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00106-005-1293-3

Schlüsselwörter

Keywords

Search

Navigation